🇺🇸 FDA
Patent

US 9320774

Method for reducing radio-resistance of prostate cancer cells and/or treating prostate cancer

granted A61KA61K38/164A61K9/1641

Quick answer

US patent 9320774 (Method for reducing radio-resistance of prostate cancer cells and/or treating prostate cancer) held by China Medical University expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
China Medical University
Grant date
Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/164, A61K9/1641, A61P, A61P13/08